日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First person – Latasha Ludwig

第一人称——拉塔莎·路德维格

Tan, David S P; Kaye, Stan; Germano, IM

A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodules

基于放射组学的决策支持工具与 Herder 评分相结合,可提高大肺结节肺癌的诊断率。

Hunter, Benjamin; Chen, Mitchell; Ratnakumar, Prashanthi; Alemu, Esubalew; Logan, Andrew; Linton-Reid, Kristofer; Tong, Daniel; Senthivel, Nishanthi; Bhamani, Amyn; Bloch, Susannah; Kemp, Samuel V; Boddy, Laura; Jain, Sejal; Gareeboo, Shafick; Rawal, Bhavin; Doran, Simon; Navani, Neal; Nair, Arjun; Bunce, Catey; Kaye, Stan; Blackledge, Matthew; Aboagye, Eric O; Devaraj, Anand; Lee, Richard W

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

定量成像检测RAD51表达作为卵巢癌铂类耐药性的标志物

Hoppe, Michal M; Jaynes, Patrick; Wardyn, Joanna D; Upadhyayula, Sai Srinivas; Tan, Tuan Zea; Lie, Stefanus; Lim, Diana G Z; Pang, Brendan N K; Lim, Sherlly; P S Yeong, Joe; Karnezis, Anthony; Chiu, Derek S; Leung, Samuel; Huntsman, David G; Sedukhina, Anna S; Sato, Ko; Topp, Monique D; Scott, Clare L; Choi, Hyungwon; Patel, Naina R; Brown, Robert; Kaye, Stan B; Pitt, Jason J; Tan, David S P; Jeyasekharan, Anand D

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037)

阿比特龙治疗复发性上皮性卵巢癌患者:II期卵巢癌阿比特龙(CORAL)试验(CRUK - A16037)的主要结果

Banerjee, Susana; Tovey, Holly; Bowen, Rebecca; Folkerd, Elizabeth; Kilburn, Lucy; McLachlan, Jennifer; Hall, Marcia; Tunariu, Nina; Attygalle, Ayoma; Lima, Joao Paulo Da Silveira Nogueira; Perry, Sophie; Chatfield, Peter; Hills, Margaret; Kaye, Stan; Attard, Gert; Dowsett, Mitch; Bliss, Judith M

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

布立伐尼治疗晚期实体瘤患者的II期随机停药试验

Jones, Robin L; Ratain, Mark J; O'Dwyer, Peter J; Siu, Lillian L; Jassem, Jacek; Medioni, Jacques; DeJonge, Maja; Rudin, Charles; Sawyer, Michael; Khayat, David; Awada, Ahmad; de Vos-Geelen, Judith M P G M; Evans, T R Jeffry; Obel, Jennifer; Brockstein, Bruce; DeGreve, Jacques; Baurain, Jean-Francois; Maki, Robert; D'Adamo, David; Dickson, Mark; Undevia, Samir; Geary, David; Janisch, Linda; Bedard, Philippe L; Abdul Razak, Albiruni R; Kristeleit, Rebecca; Vitfell-Rasmussen, Joanna; Walters, Ian; Kaye, Stan B; Schwartz, Gary

The role of genomic profiling in adolescents and young adults (AYAs) with advanced cancer participating in phase I clinical trials

基因组分析在参与 I 期临床试验的晚期癌症青少年和青年(AYA)患者中的作用

McVeigh, Terri Patricia; Sundar, Raghav; Diamantis, Nikolaos; Kaye, Stan B; Banerji, Udai; Lopez, Juanita S; de Bono, Johann; van der Graaf, Winette T A; George, Angela J

Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers

一项针对携带晚期生殖系 BRCA1/2 突变和特定散发性癌症患者的 PARP 抑制剂 Talazoparib 的 I 期剂量递增两部分试验

de Bono, Johann; Ramanathan, Ramesh K; Mina, Lida; Chugh, Rashmi; Glaspy, John; Rafii, Saeed; Kaye, Stan; Sachdev, Jasgit; Heymach, John; Smith, David C; Henshaw, Joshua W; Herriott, Ashleigh; Patterson, Miranda; Curtin, Nicola J; Byers, Lauren Averett; Wainberg, Zev A

RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses.

RNAi 筛选揭示了细胞周期蛋白 G 相关激酶和 FBXW7 之间的合成致死性,这种致死性通过诱导异常有丝分裂而产生

Dolly Saoirse O, Gurden Mark D, Drosopoulos Konstantinos, Clarke Paul, de Bono Johann, Kaye Stan, Workman Paul, Linardopoulos Spiros

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

携带 BRCA1/2 基因突变的晚期卵巢癌患者对 PARP 抑制剂奥拉帕尼抗肿瘤反应的基线临床预测因子

Rafii, Saeed; Gourley, Charlie; Kumar, Rajiv; Geuna, Elena; Ern Ang, Joo; Rye, Tzyvia; Chen, Lee-May; Shapira-Frommer, Ronnie; Friedlander, Michael; Matulonis, Ursula; De Greve, Jacques; Oza, Amit M; Banerjee, Susana; Molife, L Rhoda; Gore, Martin E; Kaye, Stan B; Yap, Timothy A

Olaparib and somatic BRCA mutations

奥拉帕尼和体细胞BRCA突变

George, Angela; Banerjee, Susana; Kaye, Stan